Agilent Technologies and Strand Scientific Intelligence have announced that they will be teaming up to expand the scope of the Agilent GeneSpring bioinformatics system across multiple life-science disciplines, drive future innovation and deliver new channels for accessing the software and customer support.
Agilent Technologies and Strand Scientific Intelligence have announced that they will be teaming up to expand the scope of the Agilent GeneSpring bioinformatics system across multiple life-science disciplines, drive future innovation and deliver new channels for accessing the software and customer support.
"Developing new scientific intelligence solutions that enable scientists to integrate, model and visualize biological information is an important part of this new agreement, and we also look forward to going beyond this, developing new ways to deliver, customize and support these solutions." said Francois Mandeville, Strand executive vice president.
"We intend to lead the way in providing tools for integrated biology research, and partnering with Strand is an excellent way of addressing the all-important bioinformatics part of the equation," said Gustavo Salem, Agilent vice president and general manager, Biological Systems Division. "Studies combining multiple 'omics experiments are finally delivering the results that were hoped for years ago from systems biology and true translational research, and this is one example of what Agilent is doing to fuel future breakthroughs in biomedical research."
The first tool scheduled to emerge from this partnership will be a version of GeneSpring designed to help users perform statistical analyses of and visualize data from genomics, metabolomics and proteomics together for the first time, using a familiar interface. The partnership also will leverage Strand's technology to enable integrated Next Generation Sequencing analysis capabilities for GeneSpring users.
For more information visit www.strandsi.com and www.agilent.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.